EBITDA for Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's current EBITDA (TTM) is $11.16B USD. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingEBITDASwitch metric
TTM (last 4 quarters)
$11.16B
YoY change
-2.8%
5Y CAGR
+2.6%
Peak year (2021)
$11.97B
Cumulative EBITDA
$119.01B
EBITDA history chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
EBITDA history table for Thermo Fisher Scientific (TMO) from 1985 to 2025
| Fiscal year | Period ended | Reported | EBITDA | YoY |
|---|---|---|---|---|
| 2025 | $11.47B | -2.8% | ||
| 2024 | $11.80B | +5.4% | ||
| 2023 | $11.20B | -6.3% | ||
| 2022 | $11.94B | -0.2% | ||
| 2021 | $11.97B | +18.4% | ||
| 2020 | $10.11B | +43.9% | ||
| 2019 | $7.02B | +13.4% | ||
| 2018 | $6.20B | +22.6% | ||
| 2017 | $5.05B | +18.9% | ||
| 2016 | $4.25B | +5.2% | ||
| 2015 | $4.04B | -5.0% | ||
| 2014 | $4.25B | +64.7% | ||
| 2013 | $2.58B | +3.5% | ||
| 2012 | $2.49B | +14.2% | ||
| 2011 | $2.18B | +14.2% | ||
| 2010 | $1.91B | +4.3% | ||
| 2009 | $1.83B | -11.6% | ||
| 2008 | $2.07B | +16.6% | ||
| 2007 | $1.78B | +254.1% | ||
| 2006 | $502.07M | +15.2% | ||
| 2005 | $435.88M | +29.6% | ||
| 2004 | $336.34M | +20.4% | ||
| 2003 | $279.30M | +44.7% | ||
| 2002 | $193.08M | -27.3% | ||
| 2001 | $265.43M | -10.2% | ||
| 2000 | $295.65M | -18.4% | ||
| 1999 | $362.20M | +2.5% | ||
| 1998 | $353.40M | -4.9% | ||
| 1997 | $371.60M | -7.0% | ||
| 1996 | $399.40M | +20.2% | ||
| 1995 | $332.30M | +37.3% | ||
| 1994 | $242.10M | +45.8% | ||
| 1993 | $166.00M | +70.3% | ||
| 1992 | $97.50M | +58.0% | ||
| 1991 | $61.70M | +13.4% | ||
| 1990 | $54.40M | +78.4% | ||
| 1989 | $30.50M | +0.7% | ||
| 1988 | $30.30M | +72.2% | ||
| 1987 | $17.60M | -15.0% | ||
| 1986 | $20.70M | +63.0% | ||
| 1985 | $12.70M | — |
EBITDA values are taken from Thermo Fisher Scientific's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of Thermo Fisher Scientific (TMO) EBITDA is $11.47B – edged down 2.8% year-over-year.
Thermo Fisher Scientific EBITDA has recorded the values shown across consecutive periods, with a +2.6% compound annual growth rate over 2020–2025 (5 years).
Between 2021 and 2025, Thermo Fisher Scientific EBITDA edged down 4.2%, falling from $11.97B to $11.47B.
2021 marks the peak EBITDA at $11.97B, with the historical low of $12.70M recorded in 1985.
Thermo Fisher Scientific (TMO) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $24.21B.
Thermo Fisher Scientific EBITDA by Year
Thermo Fisher Scientific EBITDA 2025: $11.47B
Thermo Fisher Scientific EBITDA in 2025 was $11.47B, edged down 2.8% below 2024.
Thermo Fisher Scientific EBITDA 2024: $11.80B
Thermo Fisher Scientific EBITDA in 2024 was $11.80B, grew 5.4% from 2023.
Thermo Fisher Scientific EBITDA 2023: $11.20B
Thermo Fisher Scientific EBITDA in 2023 was $11.20B, declined 6.3% below 2022.
Thermo Fisher Scientific EBITDA 2022: $11.94B
Thermo Fisher Scientific EBITDA in 2022 was $11.94B, edged down 0.2% below 2021.
Thermo Fisher Scientific EBITDA 2021: $11.97B
Thermo Fisher Scientific EBITDA in 2021 was $11.97B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers — EBITDA
Companies in the same sector as Thermo Fisher Scientific, ranked by their latest EBITDA.
| Company | EBITDA | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $156.73B | Healthcare |
| Johnson & Johnson (JNJ) | $41.05B | Healthcare |
| Eli Lilly and Company (LLY) | $27.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $25.36B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $23.06B | Healthcare |
| AstraZeneca PLC (AZN) | $19.83B | Healthcare |
| AbbVie Inc. (ABBV) | $17.63B | Healthcare |
| Amgen Inc. (AMGN) | $15.84B | Healthcare |
Frequently asked questions
What is Thermo Fisher Scientific's EBITDA?
- Latest reported EBITDA for Thermo Fisher Scientific (TMO) is $11.16B (period ending March 28, 2026).
How has Thermo Fisher Scientific EBITDA changed year-over-year?
- Thermo Fisher Scientific (TMO) EBITDA changed -2.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Thermo Fisher Scientific EBITDA?
- Thermo Fisher Scientific (TMO) EBITDA compound annual growth rate is +2.6% over the most recent 5 years available.
When did Thermo Fisher Scientific EBITDA hit its highest annual value?
- Thermo Fisher Scientific EBITDA reached its highest annual value of $11.97B in 2021.
What was Thermo Fisher Scientific EBITDA in 2024?
- Thermo Fisher Scientific (TMO) EBITDA in 2024 was $11.80B.
What was Thermo Fisher Scientific EBITDA in 2025?
- Thermo Fisher Scientific (TMO) EBITDA in 2025 was $11.47B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TMO Overview
Company profile, financial tools, and key metrics
TMO Revenue Counter
Earns $1,433 every second. See per minute, hour, and day.
TMO Earnings Counter
Earns $217.50 per second net profit. See per minute, hour, and day.
TMO Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
TMO What If Invested
What if you had invested $1,000? See historical returns from any date.
TMO How It Makes Money
Discover visual breakdown of $45.20B in revenue — where it comes from and where it goes.
TMO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TMO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TMO Daily Price Character
Balanced · 47.1% historical win rate (green days). Streaks & record days.
TMO Buybacks
4.54% TTM buyback yield. Shareholder yield & SBC comparison.
TMO Stock Split History
8 splits on record. Dates, ratios, and cumulative multiple.
TMO Dividend Profile
Yield: 0.38%. Safety: 5/8. See full history.
TMO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TMO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.